期刊文献+

NCCN结直肠癌临床实践指南2011年更新解读 被引量:62

原文传递
导出
摘要 美国国家综合癌症网络(National Comprehensive Cancer Network,NCCN)于2006年在孙燕院士倡导下引入中国,并每年进行内容更新.尽管与西方国家在人种特点、医疗体制等方面存在差异,但是,NCCN指南仍然在我国临床肿瘤诊治过程中受到极大的关注.包括2010年底首次由卫生部公布的我国《结直肠癌诊疗规范(2010年版)》也吸收了NCCN指南部分内容作为重要的参考和临床推荐[1].
出处 《中华胃肠外科杂志》 CAS 北大核心 2011年第4期234-238,共5页 Chinese Journal of Gastrointestinal Surgery
  • 相关文献

参考文献20

  • 1结直肠癌诊疗规范(2010年版)[J].中华胃肠外科杂志,2010,13(11):865-875. 被引量:163
  • 2National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:colon cancer.V.2.2011.http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.
  • 3National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:rectal cancer.V.2.2011.http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf.
  • 4姚宏伟,刘荫华.直肠癌治疗理念更新——强调术前多学科评估[J].中国实用外科杂志,2009,29(9):717-721. 被引量:8
  • 5刘荫华,徐玲,姚宏伟.2010年结直肠癌诊治观点科学解读[J].中国实用外科杂志,2010,30(9):763-768. 被引量:35
  • 6刘荫华.胃肠肿瘤综合诊治的进步与外科医生观念的转变[J].中华胃肠外科杂志,2010,13(1):19-21. 被引量:4
  • 7Edge SB,Byrd DR,Compton CC,et al.AJCC Cancer Staging Manual.7th ed.New York:Springer,2010.
  • 8Van Custem E,Lang,I,Folprecht G,et al.Cetuximab plus FOLFIRI in the treatment of metastatic colorectal cancer (mCRC):The influence of KRAS and BRAF biomarkers on outcome:Updated data from the CRYSTAL trial.ASCOGastrointestinal Cancer Symposium,2010:abstract 281.
  • 9Di Nicolantonio F,Martini M,Molinari F,et al.Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.J Clin Oncol,2008,26 (35):5705 -5712.
  • 10Bokmeyer C,Kohne C,Rougier C,et al.Cetuximab with chemotherapy as first-line treatment for metastatic colorectal cancer:Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation analysis.J Clin Oncol,2010,28suppl 15:abstract 3506.

二级参考文献51

  • 1崔龙.遗传性非息肉病性大肠癌的诊治进展[J].中国实用外科杂志,2005,25(3):189-192. 被引量:8
  • 2Chun-Yi Hao,Jia-Fu Ji. Surgical treatment of liver metastases of colorectal cancer:strategies and controversies in 2006 [J]. Eur J Surg Oncol, 2006,32 ( 5 ) :473 - 483.
  • 3Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases[J]. Gut ,2006,55 (suppl 3 ): 1-8.
  • 4Matsui O, Takashima T, Kadoya M, et al. Liver metastases from colorectal cancers: detection with CT during arterial portography [J]. Radiology,1987,165 ( 1 ) :65 -69.
  • 5Scholmerich J, Volk BA, Gerok W, Value and limitations of abdominal ultrasound in tumour staging-liver metastasis and lymphoma[ J]. Eur J Radiol, 1987,164 (7) :243 - 245.
  • 6Hagspiel KD, Neidl KF, Eichenberger AC, et al. Detection of liver metastases : comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1,5 T with dynamic CT,intraoperative US, and percutaneous US [J], Radiology, 1995,196 ( 2 ) : 471 -478.
  • 7Sheu JC, Sung JL, Chen DS, et al. Ultrasonography of small heparle tumors using high-resolution linear-array real-time instruments [ J ]. Radiology, 1984,150 ( 3 ) :797 - 802.
  • 8Pen JH,Pelekmans PA, van Maercke YM, et al. Clinical significance of focal echogenic liver lesions [ J ], Gastrointest Radiol, 1986,11(1) :61 -66.
  • 9Curati WL, Halevy A, Gibson RN, et al. Ultrasound, CT, and MRI comparison in primary and secondary tumors of the liver[ J]. Gastrointest Radiol, 1988,13 (2) : 123 - 128.
  • 10Standard for abdominal/pelvic computed tomography to investigate the liver and abdomen in oncology and criteria of quality [ EB/OL ]. Appropriateness Criteria Radiology, http ://www. aer. oig,2003.

共引文献227

同被引文献626

引证文献62

二级引证文献521

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部